This project was funded by an Independent Investigator Award (GMM) from the Brain and Behaviour Research Foundation and by Clinical Research Associates, L.L.C. (CRA), an affiliate of the Simons Foundation. Support is also acknowledged from Autistica (ACP) and the Institute for Translational Neurodevelopment at King’s College London and EU-AIMS (European Autism Interventions)/EU-AIMS-2-TRIALS, an Innovative Medicines Initiative Joint Undertaking under Grant Agreement no. 777394. In addition, this paper represents an independent research part funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London.


Project title
This project was funded by an Independent Investigator Award (GMM) from the Brain and Behaviour Research Foundation and by Clinical Research Associates, L.L.C. (CRA), an affiliate of the Simons Foundation. Support is also acknowledged from Autistica (ACP) and the Institute for Translational Neurodevelopment at King’s College London and EU-AIMS (European Autism Interventions)/EU-AIMS-2-TRIALS, an Innovative Medicines Initiative Joint Undertaking under Grant Agreement no. 777394. In addition, this paper represents an independent research part funded by the National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King’s College London.